Form 4: Accolade CEO Rajeev Singh Reports Stock Transactions
SEC Form 4 Filing
Accolade's CEO, Rajeev Singh, reports the conversion of restricted stock units and a sale of shares to cover tax obligations.
Summary
- On March 18, 2024, Rajeev Singh, CEO of Accolade, Inc., converted 933 Restricted Stock Units (RSUs) into common stock.
- On March 19, 2024, Singh sold 376 shares of common stock at a price of $9.484 per share.
- Following these transactions, Singh directly owns 745,748 shares of Accolade common stock and indirectly owns 651,619 shares through Avanti Holdings, LLC.
- The sale of shares was to cover tax withholding obligations related to the vesting and settlement of RSUs and was not a discretionary transaction.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the CEO's holdings, but the sale was primarily for tax obligations.
Key Dates
| Date | Description |
|---|---|
| June 16, 2021 | June 2021 Vesting Commencement Date for RSUs |
| March 18, 2024 | Conversion of Restricted Stock Units to Common Stock |
| March 19, 2024 | Sale of Common Stock to cover tax obligations |
| March 20, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.